Pattern Analysis of Galectin 1, 3, and 9 Serum Levels in Breast Cancer
Avery Funkhouser(National Institutes of Health), Anna V. Blenda(University of South Carolina), William J. Edenfield(Prisma Health), Julie Martin(Prisma Health), Hayden Shuster(University of South Carolina)
Cited by 2
Related Papers
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
|Journal for ImmunoTherapy of Cancer|2020|117
Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer
|Cancers|2021|36
Evaluation of BCL6 and SIRT1 as Non-Invasive Diagnostic Markers of Endometriosis
|Current Issues in Molecular Biology|2021|33